Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Deficit	Treasury Stock	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of year (in shares) at Dec. 31, 2021		10,294,824
Balance at beginning of year at Dec. 31, 2021	$ 165,769	$ 10,318	$ 197,057	$ (33,142)	$ (10,033)	$ 1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(2,537)			(2,537)
Foreign currency translation adjustment	171					171
Shares Issued (in shares)		6,065
Shares issued	0	$ 6	(6)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)		(889)
Tax withholdings related to net share settlements of stock-based compensation awards	0		33		(33)
Other	(95)		(95)
Balance at end of period (in shares) at Mar. 31, 2022		10,300,000
Balance at end of period at Mar. 31, 2022	163,308	$ 10,324	196,989	(35,679)	(10,066)	1,740
Balance at beginning of year (in shares) at Dec. 31, 2021		10,294,824
Balance at beginning of year at Dec. 31, 2021	165,769	$ 10,318	197,057	(33,142)	(10,033)	1,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(7,252)
Foreign currency translation adjustment	(2,320)
Balance at end of period (in shares) at Jun. 30, 2022		19,443,982
Balance at end of period at Jun. 30, 2022	541,828	$ 19,468	573,649	(40,394)	(10,144)	(751)
Balance at beginning of year (in shares) at Mar. 31, 2022		10,300,000
Balance at beginning of year at Mar. 31, 2022	163,308	$ 10,324	196,989	(35,679)	(10,066)	1,740
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,715)			(4,715)
Foreign currency translation adjustment	(2,491)					(2,491)
Stock-based compensation	573		573
Shares Issued (in shares)		25,682
Shares issued	0	$ 24	(24)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)		(1,867)
Tax withholdings related to net share settlements of stock-based compensation awards	(78)				(78)
Other	(39)		(39)
Issuance of common stock in rights offering (in shares)		9,120,167
Deemed consideration for reverse acquisition	351,491	$ 9,120	342,371
Reclassification of issuable shares from earnout derivative liability	26,593		26,593
Fair value adjustment of stock-based compensation awards	1,910		1,910
Settlement of related party liability	5,276		5,276
Balance at end of period (in shares) at Jun. 30, 2022		19,443,982
Balance at end of period at Jun. 30, 2022	$ 541,828	$ 19,468	573,649	(40,394)	(10,144)	(751)
Balance at beginning of year (in shares) at Dec. 31, 2022	19,730,362	19,416,784
Balance at beginning of year at Dec. 31, 2022	$ 562,995	$ 19,417	591,796	(25,736)	(12,526)	(9,956)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	5,907			5,907
Foreign currency translation adjustment	2,624					2,624
Stock-based compensation	773		773
Stock-based compensation liability paid in shares	227		227
Shares Issued (in shares)		11,144
Shares issued	0	$ 11	(11)
Settlement of earnout (in shares)		1,700,000
Shares issued - earnout	0	$ 1,700	(1,700)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)		(2,639)
Tax withholdings related to net share settlements of stock-based compensation awards	(117)	$ (3)	3		(117)
Other	0		204	(4)		(200)
Balance at end of period (in shares) at Mar. 31, 2023		21,125,289
Balance at end of period at Mar. 31, 2023	$ 572,409	$ 21,125	591,292	(19,833)	(12,643)	(7,532)
Balance at beginning of year (in shares) at Dec. 31, 2022	19,730,362	19,416,784
Balance at beginning of year at Dec. 31, 2022	$ 562,995	$ 19,417	591,796	(25,736)	(12,526)	(9,956)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,931
Foreign currency translation adjustment	$ 3,707
Balance at end of period (in shares) at Jun. 30, 2023	23,667,064	23,349,735
Balance at end of period at Jun. 30, 2023	$ 675,993	$ 23,350	688,983	(16,809)	(12,697)	(6,834)
Balance at beginning of year (in shares) at Mar. 31, 2023		21,125,289
Balance at beginning of year at Mar. 31, 2023	572,409	$ 21,125	591,292	(19,833)	(12,643)	(7,532)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,024			3,024
Foreign currency translation adjustment	1,083					1,083
Stock-based compensation	1,062		1,062
Issuance of common stock in rights offering, net of offering costs of $1,531 (in shares)		2,222,222
Issuance of common stock in rights offering, net of offering costs of $1,531	98,469	$ 2,222	96,247
Shares Issued (in shares)		3,336
Shares issued	0	$ 4	(4)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)		(1,112)
Tax withholdings related to net share settlements of stock-based compensation awards	(54)	$ (1)	1		(54)
Other	$ 0		385			385
Balance at end of period (in shares) at Jun. 30, 2023	23,667,064	23,349,735
Balance at end of period at Jun. 30, 2023	$ 675,993	$ 23,350	$ 688,983	$ (16,809)	$ (12,697)	$ (6,834)